Serina Therapeutics, Inc. Depreciation
Serina Therapeutics, Inc. (SER) reported Depreciation of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-11-13
- Serina Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $0.00.
- Serina Therapeutics, Inc. depreciation for the quarter ending 2025-06-30 was $0.00.
- Serina Therapeutics, Inc. depreciation for the quarter ending 2024-09-30 was $0.00.
- Serina Therapeutics, Inc. depreciation for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Serina Therapeutics, Inc. depreciation for fiscal 2020 was $699.00K, a 668.13% increase from fiscal 2019.
- Serina Therapeutics, Inc. depreciation for fiscal 2019 was $91.00K, a 56.90% increase from fiscal 2018.
- Serina Therapeutics, Inc. depreciation for fiscal 2018 was $58.00K, a 64.85% decline from fiscal 2017.
- Serina Therapeutics, Inc. depreciation for fiscal 2017 was $165.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | $24.00K 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2025-08-11 | $47.00K 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | $23.00K 10-Q · filed 2024-05-14 | |||||
| 2023-06-30 | $18.00K 10-Q · filed 2024-08-09 | $31.00K 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-14 | |||||
| 2020-12-31 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $452.00K derived: sum of 2 quarters · filed 2022-03-29 | $576.00K derived: sum of 3 quarters · filed 2022-03-29 | $699.00K 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $247.00K derived: sum of 2 quarters · filed 2021-11-12 | $370.00K 10-Q · filed 2021-11-12 | $423.00K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $247.00K 10-Q · filed 2021-08-13 | $300.00K derived: sum of 3 quarters · filed 2021-08-13 | $417.00K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $123.00K 10-Q · filed 2021-05-17 | $176.00K derived: sum of 2 quarters · filed 2021-05-17 | $293.00K derived: sum of 3 quarters · filed 2021-05-17 | $305.00K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $170.00K derived: sum of 2 quarters · filed 2021-03-31 | $182.00K derived: sum of 3 quarters · filed 2021-03-31 | $91.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $117.00K 10-Q · filed 2019-11-14 | $129.00K derived: sum of 2 quarters · filed 2019-11-14 | $38.00K 10-Q · filed 2020-11-16 | $149.00K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-06-30 | $12.00K 10-Q · filed 2019-08-14 | $22.00K 10-Q · filed 2020-08-14 | $32.00K derived: sum of 3 quarters · filed 2020-05-14 | $55.00K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-14 | $20.00K derived: sum of 2 quarters · filed 2020-05-14 | $43.00K derived: sum of 3 quarters · filed 2020-05-14 | $53.00K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $10.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $33.00K derived: sum of 2 quarters · filed 2020-03-31 | $43.00K derived: sum of 3 quarters · filed 2020-03-31 | $58.00K 10-K/A · filed 2020-03-31 | ||
| 2018-09-30 | $23.00K 10-Q · filed 2019-11-14 | $33.00K derived: sum of 2 quarters · filed 2019-11-14 | $48.00K 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $10.00K 10-Q · filed 2019-08-14 | $25.00K 10-Q · filed 2019-08-14 | ||||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-15 | |||||
| 2017-12-31 | $165.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |